VPIM
Vanguard Personalized Indexing Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $425K | Sell |
4,005
-4,919
| -55% | -$522K | ﹤0.01% | 1280 |
|
2025
Q1 | $1.11M | Sell |
8,924
-533
| -6% | -$66.2K | 0.02% | 732 |
|
2024
Q4 | $1.16M | Buy |
9,457
+4,054
| +75% | +$499K | 0.02% | 709 |
|
2024
Q3 | $602K | Sell |
5,403
-836
| -13% | -$93.1K | 0.01% | 1013 |
|
2024
Q2 | $664K | Buy |
6,239
+1,706
| +38% | +$182K | 0.01% | 887 |
|
2024
Q1 | $546K | Sell |
4,533
-3,068
| -40% | -$369K | 0.01% | 976 |
|
2023
Q4 | $935K | Buy |
7,601
+2,186
| +40% | +$269K | 0.02% | 687 |
|
2023
Q3 | $701K | Buy |
5,415
+1,260
| +30% | +$163K | 0.02% | 737 |
|
2023
Q2 | $515K | Sell |
4,155
-3,091
| -43% | -$383K | 0.02% | 879 |
|
2023
Q1 | $1.06M | Buy |
7,246
+3,349
| +86% | +$490K | 0.04% | 501 |
|
2022
Q4 | $621K | Sell |
3,897
-2,166
| -36% | -$345K | 0.03% | 718 |
|
2022
Q3 | $808K | Sell |
6,063
-849
| -12% | -$113K | 0.04% | 570 |
|
2022
Q2 | $1.08M | Buy |
6,912
+1,471
| +27% | +$229K | 0.05% | 429 |
|
2022
Q1 | $847K | Buy |
5,441
+3,819
| +235% | +$595K | 0.04% | 546 |
|
2021
Q4 | $207K | Buy |
+1,622
| New | +$207K | 0.01% | 986 |
|
2021
Q3 | – | Sell |
-2,052
| Closed | -$365K | – | 1018 |
|
2021
Q2 | $365K | Buy |
+2,052
| New | +$365K | 0.04% | 647 |
|